From 1 July 2015, the premium free dispensing incentive (PFDI) will be applied only when brand substitution is available.
PFDI will be paid to an Approved Supplier where the Commonwealth is satisfied that such Approved Suppliers have dispensed a listed brand where all of the following circumstances apply:
- the price of the dispensed quantity is above the patient co-payment
- the brand with the patient contribution is substitutable with one or more brands that do not have a patient contribution, and
- the brand that is dispensed does not have a patient contribution
PFDI will be indexed annually from 1 July 2016.
PFDI is not applicable to supplies and claims made from public hospitals participating in the Pharmaceutical Reform arrangements.